Boston Omaha Corp
XBER:42S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Boston Omaha Corp
XBER:42S
|
US |
|
Zomedica Corp
OTC:ZOMDF
|
US |
|
R
|
Ross Group PLC
F:8SS
|
UK |
|
A
|
Adverum Biotechnologies Inc
SWB:AVU
|
US |
|
PayGroup Ltd
ASX:PYG
|
AU |
|
WealthNavi Inc
OTC:WNAVF
|
JP |
|
Taeyoung Engineering & Construction Co Ltd
KRX:009415
|
KR |
|
Mekonomen AB
F:1OM
|
SE |
|
S
|
SW Umwelttechnik Stoiser & Wolschner AG
XBER:SWU
|
AT |
|
M
|
Mekonomen AB
LSE:0HDJ
|
SE |
|
Carlyle Commodities Corp
OTC:PONIF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 42S's stock price target?
Not Available
42S does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Boston Omaha Corp?
Projected CAGR
5%
The compound annual growth rate for Revenue over the next 2 years is 5%.